DRUGS related term(s) Crime

Addresses

New Imperialism—The Attack on World Tax Havens: Robert E. Bauman, E1868 [19OC]

Amendments

Controlled Substances Act: treatment of gamma y-hydroxybutyrate and ketamine hydrochloride (H.R. 2130), H55 [31JA]

Correctional institutions: establish grants for drug treatment alternatives to prison programs administered by State or local prosecutors (H.R. 4493), S11644 [6DE]

FDA: clarify certain responsibilities relative to importation of drugs into the U.S. (H.R. 3240), H5428 [28JN]

Native Americans: authorize the integration and consolidation of alcohol and substance abuse programs and services provided by tribal governments (S. 1507), S5054 [13JN]

Analyses

Child Protection/Alcohol and Drug Partnership Act (S. 2435), S2750 [13AP]

Offender Reentry and Community Safety Act (H.R. 5563), E1959-E1961 [27OC]

Violent and Repeat Juvenile Offender Accountability and Rehabilitation Act (S. 254): Council of State Governments, H5751 [11JY]

Appointments

Parents Advisory Council on Youth Drug Abuse, H7216 [6SE]

Articles and editorials

Abuse Program Believes in Ability Without State Aid—Faith-Based Effort Serves as Example, H6832 [25JY]

Ad Blitz Erodes Democrats' Edge on Prescription Drugs, S11290 [27OC]

Addicts Get Tough Love at Victory, H6832 [25JY]

Anti-Drug Folly—U.S. Aid Plan Would Raise Stakes in Colombian Conflict, S5500 [21JN]

Bush Hits Gore on Drugs, Taxes, S8631 [15SE]

Canada's Medicine Won't Cure U.S. System, E1104 [23JN]

Colombia Aid Bill Would Escalate a Failed Policy; Drugs—Treatment and Reducing Cocaine Consumption Is a Better Way To Go, S5500 [21JN]

Complex Drug Labels Bury Safety Message, E1027 [15JN]

Congress Must Act on Colombia, H1530 [29MR]

Cops, Crime and Clergy—Boston's Commish on How the New Alliance Between Police and Preachers Works, H6834 [25JY]

Counter-Drug Military Assistance for Colombia, S5500 [21JN]

Direct-to-Consumer Advertising of Prescription Drugs—An Ethical Perspective, S11532 [14NO]

Douglas Takes Bite Out of Award, S10404 [12OC]

Dr. Truth, S62 [26JA]

Driving Up Drug Prices, S7908 [27JY]

Drug-Industry Mergers Fail To Boost Research, Development, Study Finds, E973 [12JN]

Easter Special to Ex-Addicts, H6831 [25JY]

Easy Access to Nation's Secrets Poses Security Threat, S4654 [7JN]

Every Parent Should Take a Drug Test—Learn About Inhalants, What You Don't Know May Surprise You, H3751 [24MY]

Felons Gain Access to the Nation's Secrets, S4652-S4654 [7JN]

Florida's Drug War—Looking Back—And Ahead, S7862 [27JY]

Genetic Research—Foes of Biotechnology Ignore Global Hunger, S61 [26JA]

GOP Team, Praises Drug Rehabilitation Program, H6831 [25JY]

Gospel of St. John, H6835 [25JY]

Joint Venture—When Pot's Prescribed, the High Way Leads to the Compassion Flower Inn, E1177 [30JN]

New Holy War, H6834 [25JY]

Physician and the Pharmaceutical Detail Man—An Ethical Analysis, S11532 [14NO]

Physicians and the Pharmaceutical Industry—Is a Gift Ever Just a Gift?, E418 [27MR]

Prescription Drug Costs—Has Canada Found the Answer?, E1673 [4OC]

Probe of Security Clearances Urged—Senator Says Contract Hirings Pose a Threat, S4651 [7JN]

Rebel Attacks on 2 Colombian Villages Kill 30, H1530 [29MR]

Reckonings—Prescription for Failure, E1346 [27JY]

Saving Colombia, S2655 [13AP]

Savior of the Streets, H6833 [25JY]

Secret Agent Man—Fashion Photographer Scores Big Off Pals in the Narcotics Trade, E2155, E2157 [8DE]

State of the Union Recognition Casts San Antonio in Limelight, H6831 [25JY]

Three-Part Attack on Gore, S8750 [19SE]

To Colombians, He Is the War on Drugs, E657 [4MY]

Welfare From the Streets, H6830 [25JY]

What's So Great About Canada's Medical System?, E1460 [13SE]

Who's Afraid of Genetic Engineering?, S60 [26JA]

Who's Teaching the Doctors? Drug Firms Sponsor Required Courses—And See Their Sales Rise, E419 [27MR]

Why the High Cost of Prescription Drugs Is a Problem We Can't Afford To Ignore, H5309 [28JN]

Without Biotechnology, We'll Starve—Agricultural Genetic Engineering Is Subject to More Safeguards Than Many Unaltered Foods We Eat, S61 [26JA]

Wrong Fix, H6832 [25JY]

Bills and resolutions

Animals: increase the availability of drugs for minor species and rare diseases in all animals (see S. 3169), S9944 [5OC] (see H.R. 4780), H5435 [28JN]

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (see S. 2993), S7840 [27JY] (see H.R. 5235), H7932 [20SE] (see H.R. 5313), H8405 [27SE]

Bolivia: tribute to democracy and drug eradication efforts (see S. Res. 375), S10412 [12OC]

Children and youth: protect from drug traffickers (see H.R. 5312), H8405 [27SE]

Computers: enhance consumer protection in the purchase of prescription drugs from Internet pharmacies (see S. 3208), S10619 [17OC] (see H.R. 5476), H10036 [17OC]

Consumers: allow importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use (see S. 2520), S3691 [9MY]

———discrepancy in prescription drug prices between U.S. and foreign countries (see H. Res. 477), H2340 [13AP]

———extend interstate price discrimination prohibitions to foreign commerce relative to the discrepancy in prescription drug prices between U.S. and foreign countries (see S. 2464), S2940 [26AP] (see H.R. 4869), H6469 [18JY]

———require the U.S. Trade Representative to enter into negotiations to eliminate price controls imposed by certain foreign countries on prescription drugs (see S. 2466), S2940 [26AP] (see H.R. 4764), H5240 [27JN]

Controlled substances: treatment (see H.R. 5326), H8406 [27SE]

Correctional institutions: authorize funding for successful reentry of criminal offenders into local communities (see S. 2908), S7477 [24JY] (see H.R. 5563, 5567), H11206 [26OC]

———establish grants for drug treatment alternatives to prison programs administered by State or local prosecutors (see S. 3124), S9381 [27SE] (see H.R. 4493), H3412 [18MY]

———require pre-release drug testing of Federal prisoners (see S. 2008), S86 [26JA]

———substance abuse prevention and treatment programs in prisons funding (see S. 2619), S4378 [24MY]

Courts: establish a Federal drug court program (see S. 3191), S10411 [12OC]

———establish alternative sentencing procedures for certain nonviolent drug offenses (see H.R. 5608), H11716 [31OC]

Crime: combat manufacture, traffic, import, and export of methamphetamine (see H.R. 4248), H2238 [12AP]

———increase penalties for possessing or using a firearm in the commission of a crime and require juveniles possessing or using a firearm to be tried as adults (see H.R. 3597), H254 [8FE]

———national policy to control crime and reform court procedures (see S. 2783), S5790 [26JN]

DEA: funding to assist State and local efforts to clean up methamphetamine laboratories (see S. Res. 291), S2728 [13AP] (see H.R. 4468), H3172 [16MY]

———reimburse expenses incurred to remediate methamphetamine laboratories (see S. 2780), S5735 [23JN]

Dept. of HHS: establish Office of Correctional Health (see H.R. 4443), H2966 [11MY]

Dept. of Justice: pilot program to establish methamphetamine incident response and training teams for drug emergency areas (see H.R. 3675), H509 [16FE]

Drug abuse: combat ``Ecstasy'' production, abuse, and imports, and increase education and awareness on dangers (see S. 2612), S4297 [23MY]

Drug-Free Communities Act: reauthorize (see H.R. 5427), H9634 [10OC]

FDA: establish restrictions relative to the qualifications of physicians prescribing the abortion drug known as RU-486 (see S. 3157), S9861 [4OC] (see H.R. 5385), H8799 [4OC]

———grant authority to regulate tobacco (see S. 2333), S1986 [30MR] (see S. 2379), S2347 [6AP] (see S. 2566, 2568), S4014 [16MY] (see H.R. 4042), H1163 [21MR] (see H.R. 4207), H1956 [6AP]

———restrict authority to issue clinical holds on investigational drugs or to deny patients expanded access to such drugs (see H.R. 3677), H509 [16FE]

Federal Food, Drug, and Cosmetic Act: clinically superior modifications to previously approved or licensed drugs (see H.R. 4242), H2122 [11AP]

———provide greater access to affordable pharmaceuticals (see S. 3051), S8585 [14SE] (see H.R. 5247), H7990 [21SE]

FEMA: develop a plan for stockpiling potassium iodide tablets in areas near nuclear powerplants (see H.R. 4969), H7127 [26JY]

Health: create a national voluntary reporting system to continually reduce medical errors and improve patient safety (see S. 2743), S5240 [15JN]

———encourage private-sector distributors of the influenza vaccine to give priority to distributing the available vaccine to individuals at a high risk of developing complications from influenza (see H. Res. 672), H12066 [8DE]

———enhance the Nation's capacity to address public health threats and emergencies (see S. 2731), S5106 [14JN] (see H.R. 4964), H7127 [26JY]

———reduce accidental injury and death resulting from medical mistakes and reduce medication-related errors (see S. 2038), S489 [8FE] (see S. 2738), S5240 [15JN]

———substance abuse prevention and treatment programs funding (see S. 2527), S3692 [9MY]

———voluntary reporting of medication error information to assist in developing and disseminating recommendations and information on preventing medication errors (see H.R. 3672), H509 [16FE]

Individuals With Disabilities Education Act: authorize school personnel to discipline children with disabilities who engage in certain dangerous behavior (see S. 2517), S3612 [8MY]

Inhalants: prevent abuse (see H.R. 4565), H3868 [25MY]

Iraq: provide citizens access to U.S. food and medicines (see H.R. 3825), H641 [2MR]

Law enforcement: combat club drug trafficking, distribution, and abuse (see H.R. 4553), H3867 [25MY]

———develop and implement community policing and prosecutorial initiatives that address production, manufacture, distribution, importation, and use of illegal drugs (see S. 2850), S6574 [12JY]

Medicaid: make drug pricing information available to the public (see S. 2963), S7839 [27JY]

Medicare: allow tax deduction for Medigap and Medicare+Choice plans including outpatient prescription drug and long-term care benefits, and establish new Medigap policies including such benefits (see S. 2237), S1392 [9MR]

———coverage of drugs and biologicals (see H.R. 5501), H10472 [19OC]

———coverage of oral drugs to treat low blood calcium levels or elevated parathyroid hormone levels for patients with end stage renal disease (see H.R. 4628), H4174 [9JN]

———coverage of outpatient prescription drugs (see S. 2758), S5460 [20JN] (see S. 2836), S6257 [30JN] (see S. 3016, 3017), S8197 [7SE] (see S. 3107), S9267 [26SE] (see H.R. 4149), H1674 [3AP] (see H.R. 4607), H4120 [8JN] (see H.R. 4743), H5168 [26JN] (see H.R. 4770), H5240 [27JN] (see H.R. 5151), H7501 [12SE] (see H. Res. 435), H756 [8MR]

———coverage of outpatient prescription drugs and enhanced preventative benefits (see S. 2541), S3832 [10MY] (see S. 2753), S5360 [19JN]

———coverage of pharmaceutical care services (see H.R. 5140), H7365 [7SE]

———coverage of self-administered drugs that, when used as a replacement for covered drugs, result in overall cost savings to the program (see H.R. 4375), H2511 [3MY]

———create official website that allows beneficiaries to purchase safe and competitively priced domestic and international prescription drugs (see H.R. 5142), H7365 [7SE]

———eliminate time limitation on benefits for immunosuppressive drugs (see S. 2399), S2527 [11AP]

———establish a voluntary plan under which eligible beneficiaries may elect to receive coverage for outpatient prescription drugs (see S. 2319), S1884 [29MR]

———establish a voluntary program for low-income beneficiaries to obtain assistance in paying for outpatient prescription drugs (see H.R. 4235), H2121 [11AP]

———expand coverage of certain self-injected biologicals (see S. 2644), S4460 [25MY] (see S. 2957), S7839 [27JY]

———improve payments under the Medicare+Choice program (see H.R. 4236), H2122 [11AP]

———make improvements to the Medicare+Choice program (see S. 2905), S7448 [21JY] (see H.R. 5039), H7207 (see H.R. 5099), H7209 [27JY] (see H.R. 5320), H8405 [27SE] (see H.R. 5614), H11781 [1NO]

———make more competitive and efficient and provide for a prescription drug benefit (see S. 2342), S2106 [4AP] (see S. 2807), S6015 [28JN] (see H.R. 4680), H4591 [15JN]

———make more competitive and efficient and provide for a prescription drug benefit (H.R. 4680), consideration (see H. Res. 539), H5239 [27JN]

———promote research for health promotion and disease prevention and add preventive benefits (see S. 2232), S1392 [9MR] (see H.R. 3887), H920 [9MR]

———reductions in prescription drug prices for beneficiaries and women with breast cancer (see H.R. 5467), H9900 [12OC]

———revise coverage of immunosuppressive drugs (see H.R. 5276), H8061 [25SE]

———waive waiting period for coverage of individuals disabled with AIDS and provide coverage of drugs used for treatment (see H.R. 4557), H3867 [25MY]

Methamphetamines: facilitate environmental cleanup caused by the manufacture of methamphetamines and impose new monetary fines for the manufacture and trafficking of methamphetamines (see H.R. 5589), H11445 [27OC]

Mexico: grant a temporary waiver of requirements relative to foreign aid certification of drug enforcement efforts (see S. 3021), S8197 [7SE] (see S. Res. 366), S9861 [4OC] (see H.R. 5155), H7502 [12SE]

Montana: designate certain counties as High Intensity Drug Trafficking Areas and authorize funding for drug control activities in those areas (see S. 2238), S1392 [9MR]

Motor vehicles: prohibit operation with drugs or alcohol in the body of the driver at a land border port of entry (see H.R. 4329), H2339 [13AP]

National Alcohol and Drug Addiction Recovery Month: designate (see S. Res. 351), S8342 [11SE]

———support goals and ideas (see H. Con. Res. 371), H6052 [13JY]

National Community Antidrug Coalition Institute: establish (see S. 2473), S2940 [26AP]

National Eat-Dinner-With-Your-Children Day: designate (see S. Res. 323), S5106 [14JN]

National Vaccine Injury Compensation Program: amend (see H.R. 5327), H8406 [27SE] (see H.R. 5330), H8468 [28SE]

———revise compensation rules for vaccines administered before effective date of such program (see H.R. 5168), H7577 [13SE]

NIH: biomedical research funding (see S. Res. 253), S381 [7FE] (see H. Res. 437), H921 [9MR]

NIST: establish a program to support research and training in methods of detecting the use of performance-enhancing substances by athletes (see S. 2267), S1596 [22MR] (see S. 2340), S2040 [3AP]

Panama Canal: negotiate new agreement relative to the presence of U.S. Armed Forces (see S. Res. 257), S613 [10FE] (see H.R. 3673), H509 [16FE]

Pharmaceuticals: abbreviate applications for the approval of new drugs (see H.R. 5231), H7932 [20SE]

———availability of HIV/AIDS pharmaceuticals and medical technologies in sub-Saharan Africa and other developing countries (see H.R. 5101), H7210 [27JY]

———provide access and choice for use of generic drugs under Federal health care programs (see S. 2501), S3328 [3MY]

———provide for prices that are fair to the producer and the consumer (see H.R. 4772), H5240 [27JN]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (see H.R. 3636), H340 [10FE]

Prescription drugs: distribution (see H.R. 4301), H2338 [13AP]

Schools: ensure implementation of adequate safeguards before distributing certain prescribed medications to students (see H.R. 4083), H1405 [23MR]

———provide notification to State educational agencies regarding the availability of funds to establish school safety hotlines (see H.R. 5123), H7364 [7SE]

Social Security: create a grant program to promote joint activities between Federal, State, and local child welfare and alcohol and drug abuse prevention and treatment agencies (see S. 2435), S2728 [13AP] (see H.R. 5081), H7209 [27JY]

States: clarify application of Federal controlled substances laws in States that authorize medical use of marijuana and other drugs (see H.R. 4802), H5655 [29JN]

Substance Abuse and Mental Health Services Administration: revise and extend programs (see H.R. 4867), H6354 [17JY]

Tariff: Exisulind (see S. 2862), S6677 [13JY] (see H.R. 4767), H5240 [27JN]

———HIV/AIDS drugs (see S. 2129, 2130), S1024 [1MR]

———R115777 (see S. 2628), S4379 [24MY]

———rhinovirus drugs (see S. 2131), S1024 [1MR]

———(S)-6-chloro-3,4-dihydro-4-cyclopropylethynyl-4-trifluoromethyl-2(1H)-quinazolinone (see S. 2391), S2526 [11AP]

———(S)-6-chloro-3,4-dihydro-4-E-cyclopropylethynyl-4-trifluoromethyl-2(1H)-quinazolinone (see S. 2392), S2526 [11AP]

Taxation: allow a credit to individuals attaining age 65 for certain drug and health insurance expenses (see H.R. 4234), H2121 [11AP]

———allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (see H.R. 4472), H3172 [16MY]

———allow credit against income tax for research to develop vaccines against widespread diseases and ensure that such vaccines are affordable and widely distributed (see H.R. 5219), H7932 [20SE]

———deny tax benefits for research conducted by pharmaceutical companies where U.S. consumers pay more for products of that research than foreign consumers (see S. 2465), S2940 [26AP] (see H.R. 3665), H454 [15FE]

———impose a discriminatory profits tax on pharmaceutical companies that charge higher prices to domestic wholesale distributors than to foreign wholesale distributors (see S. 3103), S9195 [25SE]

———treatment of certain gifts and benefits provided to physicians by prescription drug manufacturers (see H.R. 4088, 4089), H1405 [23MR]

———treatment of direct-to-consumer advertisements of prescription drugs that fail to provide certain information to the consumer (see H.R. 4686), H4591 [15JN]

Tobacco products: increase legal age for smoking (see H.R. 4432), H2966 [11MY]

Briefs

Medicare+Choice reimbursement system: Minnesota congressional delegation, E1173-E1176 [30JN]

Descriptions

Drug Dealer Liability Act (H.R. 1042), H9536 [10OC]

Excerpts

Court depositions in Chetan Desai, et al. v. Jayaprakash K. Kamath, et al. relative to profits from the sale of chemotherapy drugs, E1578 [25SE]

Executive orders

Access to HIV/AIDS pharmaceuticals and medical technologies in sub-Saharan African countries: President Clinton, S3802 [10MY]

Factsheets

Child Protection/Alcohol and Drug Partnership Act (S. 2435), S2751 [13AP]

Clinton Administration's Colombia Aid Proposal, H1054 [15MR]

Growing Emergency in Colombia, H1054 [15MR]

Voluntary Error Reduction and Improvement in Patient Safety Act (S. 2743), S5269 [15JN]

What About Human Rights Abuses in Colombia?, H1054 [15MR]

Why Colombia Matters to the U.S., H1054 [15MR]

Invitations

Treatment of diabetic patients: Bristol-Myers Squibb, Inc., E11 [27JA]

Letters

Access to HIV/AIDS pharmaceuticals and medical technologies in sub-Saharan African countries: President Clinton, S3795 [10MY]

Amyotrophic Lateral Sclerosis (ALS) Treatment and Assistance Act: Senator Torricelli, S9890 [5OC]

Assignment of Armed Forces personnel to assist the INS and Customs Service with border control activities: Brian E. Sheridan, Dept. of Defense, E793 [19MY]

Biotechnology research: several scientists, S63 [26JA]

Buprenorphine use in treating drug addiction: Donna E. Shalala, Sec. of HHS, S9112 [22SE]

Colombian counter-drug efforts: Andres Pastrana, President of Colombia, S5498 [21JN]

Colombian drug enforcement efforts relative to procurement of helicopters: Colombian Ministry of Defense, S5529 [21JN]

Colombian drug interdiction assistance: Representatives Burton and Gilman, H5925 [12JY]

———Representatives McGovern and Moakley, H493 [16FE]

Date-Rape Drug Prohibition Act: Ward Dean, H61 [31JA]

District of Columbia inclusion of conscience clause in legislation mandating coverage of contraceptives by health insurance plans: Dennis M. Schnurr, National Conference of Catholic Bishops, H7056 [26JY]

Drug Addiction Treatment Act: Representative Bliley, Committee on Commerce (House), H6376 [18JY]

———Representative Hyde, Committee on the Judiciary (House), H6376 [18JY]

Enhance the Nation's capacity to address public health threats and emergencies: Dyann F. Wirth, American Society of Tropical Medicine and Hygiene, S11311 [28OC]

———Gail H. Cassell, American Society for Microbiology, S11311 [28OC]

———Jean-Pierre Garnier, SmithKline Beecham (business), S11312 [28OC]

———Jordan J. Cohen, Association of American Medical Colleges, S11310 [28OC]

———Ronald L. Cada, Association of Public Laboratories, S11311 [28OC]

———several medical and health organizations, S11310 [28OC]

———Stephanie B.C. Bailey, National Association of County and City Health Officials, S11311 [28OC]

———William J. Martone, National Foundation for Infectious Diseases, S11311 [28OC]

Facilitate the importation into the U.S. of certain FDA approved drugs: several Representatives, H5428 [28JN]

FDA investigation of drug manufacturer pricing practices: Representative Stark, E1656 [3OC], E1764 [12OC], E1792 [13OC]

FDA investigation of drug manufacturer pricing practices relative to Medicare and Medicaid: Fred Hassan, Pharmacia Corp., E1883 [23OC]

———Representative Stark, E2033, E2037-E2039 [31OC]

Grant FDA authority to regulate tobacco, and reduce youth smoking, increase tobacco-related research, and develop safer tobacco products: John R. Garrison, American Lung Association, E371 [21MR]

Importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use: David A. Kessler, S9258 [26SE]

———Michael E. Baroody, National Association of Manufacturers, H9702 [11OC]

———Michael M. Faenza, National Mental Health Association, H9702 [11OC]

———Mike Dugan, National Multiple Sclerosis Society, H9702 [11OC]

———Nancy Sander, Allergy and Asthma Network-Mothers of Asthmatics, Inc., H9703 [11OC]

———Representative Archer, S10685 [18OC]

———Representative Dingell, Committee on Commerce (House), S10684 [18OC]

———Representative Hyde, Committee on the Judiciary (House), S10688 [18OC]

———Senator Hatch, Committee on the Judiciary (Senate), S10688 [18OC]

———Thomas J. Donohue, U.S. Chamber of Commerce, H9702 [11OC]

———several Representatives, H9703 [11OC]

———several patient and survivor organizations, H9703 [11OC]

Internet Prescription Drug Consumer Protection Act: Carla J. Stovall, National Association of Attorneys General, S10621 [17OC]

———Henri R. Manasse, Jr., American Society of Health-Systems Pharmacists, S10622 [17OC]

———John A. Gans, American Pharmaceutical Association, S10621 [17OC]

———Linda F. Golodner, National Consumers League, S10622 [17OC]

———Peter M. Neupert, drugstore.com, Inc., S10622 [17OC]

Medicare coverage of outpatient prescription drugs, E1882 [23OC]

———Adam Zaveski, E1179 [30JN]

———Gail Rattigan, S837 [28FE]

———Harriett Simmons, H8894 [5OC]

———Horace B. Deets, Leadership Council of Aging Organizations, E124 [10FE]

———Julia Kanopsky, H4169 [9JN]

———Louise Jarnac, H3401 [18MY]

———Mary Hudson, H9806 [11OC]

———Paul and Lois Van Valkenburgh, H8281 [27SE]

———Representative Stark, Committee on Ways and Means (House), E279 [9MR]

———Virginia Langell, H7900 [20SE]

Medicare reimbursement of prescription drug costs at the average wholesale price: Representative Stark, Committee on Ways and Means (House), E1620, E1622-E1624 [28SE]

Medicare Rx 2000 Act: Laurie M. Flynn, National Alliance for the Mentally Ill, H5359 [28JN]

Medicare+Choice program improvements: several senior citizen organizations, S10669 [18OC]

NIH biomedical research funding: Anna D. Barker and Margaret Foti, American Association for Cancer Research, Inc., H7074 [26JY]

———Corrina P. Smith, PolyCystic Ovarian Syndrome Association, Inc., H7084 [26JY]

———Cynthia Clay, H7084 [26JY]

———Darwin J. Prockop, MCP Hahnemann University, H7074 [26JY]

———David B. Moore, Ad Hoc Group for Medical Research Funding, H7074 [26JY]

———David G. Kaufman, Federation of American Societies for Experimental Biology, H7073 [26JY]

———Eric S. Lander, Joint Steering Committee for Public Policy, H7073 [26JY]

———Gerald Litwack, Jefferson Medical College, H7074 [26JY]

———Lawrence S.B. Goldstein, University of California, San Diego, H7084 [26JY]

———Lynn Smaha, American Heart Association, H7073 [26JY]

———Rajen Dalal, Chiron Corp., H7084 [26JY]

———several Representatives, H7073 [26JY]

Prescription drug importation into the U.S. by pharmacists and wholesalers for resale: John M. Rector, National Community Pharmacists Association, S7377 [20JY]

———Representative Dingell, S7206 [19JY]

———Ronald J. Streck, National Wholesale Druggists' Association, S7206 [19JY]

Reinstate reasonable pricing requirements for drugs developed with Federal funding or research: Dan Schulder, National Council of Senior Citizens, S6097 [29JN]

———Martha A. McSteen, National Committee to Preserve Social Security and Medicare, S6097 [29JN]

———Ronald F. Pollack, Families USA (organization), S6097 [29JN]

Transfer of appropriations from other Federal departments and agencies to fund Dept. of Justice litigation against tobacco industry: several veterans organizations, H4496 [15JN]

Urgent support for Colombia to secure peace and the rule of law, and to enhance the effectiveness of anti-drug efforts: Representative Lantos, H1530 [29MR]

Use of counter-drug military assistance for Colombia to fund domestic substance abuse and mental health services: several religious leaders, S5491 [21JN]

———several substance abuse organizations, S5489 [21JN]

Voluntary Error Reduction and Improvement in Patient Safety Act: Andrew Dreyfus, Massachusetts Hospital Association, S5270 [15JN]

———David Johnson, Federation of Behavioral, Psychological and Cognitive Sciences, S5270 [15JN]

Voluntary Medicare Prescription Drug Plan Act: Mark E. Litow, Milliman & Robertson, Inc., S2652 [13AP]

———Roland E. (Guy) King, King Associates (business), S2651 [13AP]

Voluntary plan under which eligible Medicare beneficiaries may elect to receive coverage for outpatient prescription drugs: Roland E. (Guy) King, King Associates (business), S1901 [29MR]

Lists

Biomedical Research Caucus events, H7078 [26JY]

Cosponsors of H. Res. 437, NIH biomedical research funding, H7073 [26JY]

Legislation cleared by Congress, signed into law, or en route to the President for his signature since Labor Day, S10887 [23OC]

Supporters of H. Res. 437, NIH biomedical research funding, H7074 [26JY]

Voluntary Medicare Prescription Drug Plan Act savings for monthly expenses, S2653 [13AP]

Memorandums

Facilitate the Importation Into the U.S. of Certain FDA Approved Drugs: Christopher J. Sroka, Congressional Research Service, H5430 [28JN]

Physician Prescribing Practices in Japan, E1620 [28SE]

Messages

National Emergency Relative to Narcotics Traffickers in Colombia: President Clinton, S3256 [2MY], S10799 [19OC], S11128 [26OC], H2374 [2MY], H10461 [19OC], H11297 [26OC]

Motions

Medicare: make more competitive and efficient and provide for a prescription drug benefit (H.R. 4680), H5383, H5397, H5398 [28JN]

———make more competitive and efficient and provide for a prescription drug benefit (H.R. 4680), consideration (H. Res. 539), H5303, H5316, H5317 [28JN]

Opinion polls

Prescription drug plan for stronger Medicare: Glen Bolger, Public Opinion Strategies (business), S4975 [13JN]

Press releases

FTC Charges Drug Manufacturers With Stifling Competition in Two Prescription Drug Markets: FTC, H5309 [28JN]

Proclamations

National Biotechnology Month: President Clinton, S60 [26JA]

Questions and answers

Medicare coverage of outpatient prescription drugs: Senators Domenici and Graham, S5646 [22JN]

Regulations

Hospital Outpatient Department prospective payment system for prescription drugs: Health Care Financing Administration, E1276 [19JY]

Remarks in House

Agriculture: eliminate use of antibiotic drugs in livestock unless there is a reasonable certainty of no harm to human health, H6359 [18JY]

AID: U.N. Drug Control Program economic development activities funding, H1555 [29MR]

Animals: increase the availability of drugs for minor species and rare diseases in all animals (H.R. 4780), E1146 [29JN]

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (H.R. 5235), E1538 [20SE]

Armed Forces: assignment of personnel to assist the INS and Customs Service with border control activities, H3275-H3277 [17MY], H3312 [18MY], H6604 [20JY], E766 [18MY]

———limit number of military personnel in Colombia, H1542, H1543 [29MR], H1610, H1611 [30MR]

———use of personnel to strengthen drug enforcement activities along U.S.-Mexico border, H614 [1MR], H1080 [16MR], H1633 [3AP], H11200 [26OC]

Baltimore, MD: needle exchange program, H3643 [23MY]

Black History Month: observance, H149-H154 [1FE]

Budget: allocation of funds, H258 [9FE]

———ensure Medicare coverage of prescription drugs prior to consideration of any tax cuts, H1976-H1984 [10AP]

———treatment of any budget surpluses, E1218 [13JY]

California: California: Substance Abuse and Crime Prevention initiative, H8914 [5OC]

———tribute to National Guard for efforts to combat illegal drugs, E1670 [4OC]

Caribbean nations: drug interdiction assistance, H3645 [23MY]

Children and youth: authorize grants for education programs to combat inhalant abuse, H3751 [24MY]

———protect from drug traffickers (H.R. 5312), H9950, H9951 [17OC], E1865 [19OC]

Cincinnati, OH: Reading Community Junior Senior High School Esteem Team recipient of Ohio BEST Practices Award, E2134 [6DE]

Coast Guard: funding, H1021, H1022 [15MR]

Colombia: authorize urgent support to secure peace and the rule of law, and to enhance the effectiveness of anti-drug efforts, H610 [1MR], H704 [8MR], H760 [9MR], H939, H981 [14MR], H1000, H1053, H1062 [15MR], H1080 [16MR], H1141 [21MR], H1248 [22MR], H1287 [23MR], H1486-H1493, H1504-H1513, H1552-H1554 [29MR], H1617, H1618 [30MR], H1746-H1751 [4AP]

———condition military assistance upon certification of efforts to eliminate drug production and combat human rights abuses, H1543-H1546 [29MR]

———drug interdiction and counter-drug military assistance funding, H1521-H1540 [29MR], H1617, H1618 [30MR]

———drug interdiction assistance, H159-H161 [1FE], H379, H437-H442 [15FE], H492 [16FE], H2763-H2768 [9MY], H3644 [23MY], H5599, H5604, H5613-H5616 [29JN], H5924, H5925 [12JY], H6022 [13JY], H7242, H7248-H7253 [6SE]

———eliminate all drug interdiction and counter-drug military assistance funding in emergency supplemental appropriations, H1608-H1610 [30MR]

Committee on Government Reform (House): review of health care activities, E2230 [15DE]

Committee on Science (House): release of report on plant genome science, H2016 [11AP]

Computers: enhance consumer protection in the purchase of prescription drugs from Internet pharmacies (H.R. 5476), E1808 [17OC]

Congress: accomplishments of the 106th Congress, H1 [24JA], H5848, H5850 [12JY], H6783 [25JY], H10755 [24OC]

Consumers: allow importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use, H7875 [20SE], H7937, H7938 [21SE], H8206 [27SE], H9638, H9639, H9670, H9672-H9680, H9693-H9708 [11OC], H10394 [19OC], E1866 [19OC], E1891 [24OC], E1903 [25OC]

———discrepancy in prescription drug prices between U.S. and foreign countries, H5427-H5433 [28JN], H5849 [12JY], H7875, H7907-H7914 [20SE], H8052, H8053 [25SE], H11753 [1NO], E1460 [13SE]

Controlled Substances Act: civil liability for illegal manufacturers and distributors of controlled substances (H.R. 1042), H9535-H9537 [10OC]

———treatment of gamma y-hydroxybutyrate and ketamine hydrochloride (H.R. 2130), H55-H62 [31JA]

Correctional institutions: authorize funding for successful reentry of criminal offenders into local communities (H.R. 5563), E1959 [27OC]

———establish grants for drug treatment alternatives to prison programs administered by State or local prosecutors (H.R. 4493), H9951-H9954 [17OC]

Courts: minimum mandatory sentencing, H150 [1FE]

Crime: combat manufacture, traffic, import, and export of methamphetamine (H.R. 4248), H2125, H2126, H2127 [12AP], E545 [12AP]

———national policy to control crime and reform court procedures, E1097 [23JN]

DEA: funding to assist State and local efforts to clean up methamphetamine laboratories, H5046, H5071 [23JN], H11291 [26OC], E474 [3AP]

Dearden, Dennis: Gang Resistance Education and Training Program National Principal of the Year award recipient, E51 [1FE]

Democratic Party: national agenda, H8592 [2OC]

Dept. of Defense: expand drug interdiction and counterdrug activities, H158-H163 [1FE], H981-H983 [14MR]

———TRICARE senior pharmacy program funding through reductions in the national missile defense system, H3992-H3999 [7JN]

Dept. of HHS: establish Office of Correctional Health (H.R. 4443), E715 [11MY]

———senior citizens programs funding, H4297-H4300 [13JN]

Dept. of HUD: modify eligibility requirements for Public and Assisted Housing Drug Elimination Program grants, H1936, H1937 [6AP]

Dept. of Justice: Weed and Seed Program funding, H5151 [26JN]

———Weed and Seed Program funding through reductions in FBI salaries and expenses, H4993 [22JN]

Diseases: AIDS epidemic, H7283 [7SE]

District of Columbia: inclusion of conscience clause in legislation mandating coverage of contraceptives by health insurance plans, H7055-H7058 [26JY], H7176 [27JY], H7583, H7584 [14SE]

———prohibit location of needle exchange programs within 1,000 feet of areas where children may be present, H7588-H7590 [14SE], H8752, H8753 [4OC]

———prohibit needle exchange programs funding, H7031, H7032, H7034, H7035, H7050-H7053 [26JY], H7283 [7SE]

Drug abuse: combat ``Ecstasy'' production, abuse, and imports, and increase education and awareness on dangers, H8251 [27SE]

———combat methamphetamine production and abuse, H1482, H1540, H1541 [29MR], E461, E464, E468 [30MR], E2221 [15DE]

———international narcotics control funding, H437-H442 [15FE], H1505, H1506, H1552-H1554 [29MR], H2763-H2768 [9MY], H4776-H4779 [20JN]

———national drug control policy, H158-H163 [1FE], H437-H442 [15FE], H610, H614 [1MR], H979-H983 [14MR], H1062 [15MR], H1080 [16MR], H1468-H1473 [28MR], H1746-H1751 [4AP], H2115-H2120 [11AP], H2763-H2768 [9MY], H3165-H3169 [16MY], H3642-H3646 [23MY], H3913-H3918 [6JN], H4333 [13JN], H4776-H4779 [20JN], H5741, H5836-H5841 [11JY], H6042-H6047 [13JY], H6461-H6466 [18JY], H7248-H7253 [6SE], H7864-H7868 [19SE], H8192-H8195 [26SE], H8909-H8914 [5OC], H9897 [12OC], H9910 [17OC], H11777-H11779 [1NO]

Drug courts: funding through reductions in truth-in-sentencing prison construction grants, H5011, H5012, H5014 [22JN]

Drugs: substance abuse prevention and treatment programs funding, H1141 [21MR], H1482, H1490, H1492, H1493, H1494, H1524-H1540 [29MR], H1619 [30MR]

Eckerd Corp.: sponsorship of ``Drug Quiz Show'' drug abuse education program, E598 [2MY]

Education: suspend student loans to individuals convicted of drug offenses, H610 [1MR]

Eugene, OR: tribute to local television stations for simulcast of documentary about the effects of drug abuse, E360 [21MR]

FDA: Center for Veterinary Research funding for antibiotic drugs for livestock, H5684, H5685 [10JY], H5817 [11JY], E1209 [11JY], E1760 [12OC]

———clarify certain responsibilities relative to importation of drugs into the U.S. (H.R. 3240), H360 [14FE], H1731 [4AP], H2096 [11AP], H2635 [8MY], H3858 [25MY], H5426-H5434 [28JN], E1235 [14JY]

———consolidation of offices funding, H6652-H6654 [20JY], E1374 [27JY]

———facilitate the importation into the U.S. of certain approved drugs (H.R. 1885), H1945, H1946 [6AP], H5428, H5430 [28JN], H7913, H7915 [20SE], E1235 [14JY]

———grant authority to regulate tobacco, H7087-H7090 [26JY], E1169 [30JN]

———grant authority to regulate tobacco (H.R. 4042), H1127 [21MR], E371 [21MR]

———grant authority to regulate tobacco (H.R. 4207), H1847-H1849 [5AP], H2114 [11AP], H2503 [3MY]

———investigate drug manufacturer pricing practices relative to Medicare, E1655 [3OC], E1764 [12OC], E1792 [13OC]

———investigation of drug manufacturer pricing practices relative to Medicare and Medicaid, E1882 [23OC], E2033, E2037 [31OC]

———prohibit funding for research, development, and approval of any drug for chemical inducement of abortion, H5693, H5694 [10JY], E1212 [11JY]

———prohibit funding to prevent importation into the U.S. of certain approved drugs, H5696-H5700, H5705-H5709 [10JY], E1198 [11JY]

———prohibit funding to vaccine-related advisory committees that grant conflicts of interest waivers, H5777-H5779 [11JY]

———restrict authority to issue clinical holds on investigational drugs or to deny patients expanded access to such drugs (H.R. 3677), E2230 [15DE]

———Supreme Court decision relative to jurisdiction over tobacco, H1288 [23MR]

Federal-State relations: reduce State and local costs due to unfunded Federal mandates relative to Medicare Rx 2000 Act, H5301, H5302 [28JN]

Foreign policy: prohibit any agent of the U.S. from pressuring African countries to change or revoke laws aimed at increasing access to HIV/AIDS drugs, H2587 [4MY], E734 [16MY]

Gagne, Len: tribute to efforts relative to delivery of prescription drugs to military retirees in Oregon, H928 [13MR]

Government: impact of regulations on personal liberties, H186 [2FE]

Government regulations: registration requirements for practitioners who dispense narcotic drugs for maintenance or detoxification treatment (H.R. 2634), H6374-H6377 [18JY]

Haiti: U.S. policy, H7194 [27JY]

Health: encourage private-sector distributors of the influenza vaccine to give priority to distributing the available vaccine to individuals at a high risk of developing complications from influenza (H. Res. 672), E2160 [8DE]

———enhance the Nation's capacity to address public health threats and emergencies, H11313 [26OC]

———frequency of antibiotic use relative to increase in drug resistant infectious disease, H6359 [18JY]

———recognize differences in organ transplantation between adults and children and study immunosupressive drugs provided to children, H1700, H1701 [4AP]

———reduce accidental injury and death resulting from medical mistakes and reduce medication-related errors, H7006 [26JY]

———review of immunization and vaccine programs, E2230 [15DE]

———shortage of influenza vaccinations, E2015 [28OC]

———substance abuse prevention and treatment programs funding, H1141 [21MR], H1482, H1490, H1492, H1493, H1494, H1524-H1540 [29MR], H1619 [30MR], H4197-H4201 [12JN]

Hear O'Israel International, Inc.: tribute to Listen to the Cries of the Children National Campaign 2000, E861 [25MY]

House of Representatives: legislative priorities, H8909-H8914 [5OC], H9458-H9461 [6OC], H10450-H10452 [19OC], H10803-H10805 [24OC], H11594 [30OC]

Insurance: provide nondiscriminatory coverage of substance abuse treatment services under private group and individual health coverage (H.R. 1977), H1062 [15MR]

International Conference on Ethnomedicine and Drug Discovery: tribute, E161 [16FE]

ITC: study the impact of prescription drug prices on the economy, E1299 [21JY]

Jackson County, OR: tribute to law enforcement personnel involved in collaborative counter-drug efforts, H762 [9MR]

Law enforcement: combat club drug trafficking, distribution, and abuse (H.R. 4553), H3857 [25MY]

Medicare: coverage of chronic disease prescription drugs (H.R. 1796), E1866 [19OC]

———coverage of outpatient prescription drugs, H16-H18 [27JA], H79 [31JA], H367 [14FE], H496-H501 [16FE], H579, H580 [1MR], H1000 [15MR], H1127 [21MR], H1303, H1304, H1305, H1333 [23MR], H1945, H1946 [6AP], H2186, H2190-H2200 [12AP], H2257, H2320 [13AP], H2485, H2488-H2501 [3MY], H2619 [8MY], H2974 [15MY], H3057 [16MY], H3183, H3184, H3185 [17MY], H3312, H3313, H3401 [18MY], H3620-H3625 [23MY], H3934, H3963 [7JN], H4168 [9JN], H4226 [13JN], H4343, H4345, H4480 [14JN], H4596, H4659-H4670 [19JN], H4679, H4680 [20JN], H4910, H4911, H4916-H4928 [21JN], H5077 [23JN], H5175 [27JN], H5821-H5827 [11JY], H5878-H5880 [12JY], H6031 [13JY], H6097-H6102 [17JY], H6526-H6528, H6566, H6569, H6570, H6573-H6576 [19JY], H7067 [26JY], H7221, H7253-H7259 [6SE], H7284, H7348 [7SE], H7546, H7563 [13SE], H7707-H7715 [18SE], H7875, H7899, H7902-H7916 [20SE], H7936, H7937, H7938, H7939, H7968-H7970, H7983-H7985 [21SE], H8036, H8041-H8047, H8052 [25SE], H8066 [26SE], H8205, H8206, H8281, H8298, H8299 [27SE], H8410, H8411 [28SE], H8629, H8732-H8734 [3OC], H8744, H8796 [4OC], H8894 [5OC], H9454, H9455 [6OC], H9706, H9806 [11OC], H10240 [18OC], H10399 [19OC], H10816, H10882, H10892-H10905 [25OC], H11435-H11442 [27OC], H11476-H11483 [28OC], H11535, H11595-H11601, H11609 [30OC], H11750, H11754-H11761 [1NO], H11786, H11792, H11803-H11807 [2NO], H12036-H12040 [7DE], E123 [10FE], E279 [9MR], E531 [11AP], E697 [10MY], E722 [15MY], E1179 [30JN], E1302 [21JY], E1346 [27JY], E1485 [14SE], E1613 [27SE], E1673 [4OC], E1779 [13OC], E1866 [19OC], E1882 [23OC], E1910 [25OC]

———coverage of outpatient prescription drugs for military retirees, H7507 [13SE], H9642 [11OC]

———coverage of outpatient prescription drugs (H.R. 1495), H458, H459, H460, H461 [16FE], H1461-H1463 [28MR], E411 [23MR]

———coverage of outpatient prescription drugs (H.R. 3482), H3753 [24MY]

———coverage of outpatient prescription drugs (H.R. 4607), E951 [9JN]

———coverage of outpatient prescription drugs (H.R. 4770), H5426 [28JN], E1188 [10JY], E1276 [19JY]

———create official website that allows beneficiaries to purchase safe and competitively priced domestic and international prescription drugs (H.R. 5142), E1423 [7SE]

———establish a voluntary plan under which eligible beneficiaries may elect to receive coverage for prescription drugs, H4293-H4296 [13JN]

———improve payments under the Medicare+Choice program (H.R. 4236), E527 [11AP]

———make improvements to the Medicare+Choice program, H10816 [25OC], H11806 [2NO]

———make more competitive and efficient and provide for a prescription drug benefit (H.R. 4680), H4916 [21JN], H5073, H5077, H5078, H5079 [23JN], H5088 [26JN], H5173 [27JN], H5319-H5415 [28JN], H5439, H5440, H5441, H5442 [29JN], H6781 [25JY], H7852-H7858 [19SE], H7977-H7983 [21SE], H8110 [26SE], H8745 [4OC], H9701 [11OC], H11532 [30OC], E1104 [23JN], E1159, E1162, E1172, E1179 [30JN], E1188 [10JY], E1203 [11JY]

———make more competitive and efficient and provide for a prescription drug benefit (H.R. 4680), consideration (H. Res. 539), H5300-H5318 [28JN]

———make more competitive and efficient and provide for a prescription drug benefit (H.R. 4680), motion to recommit, H5396 [28JN]

———promote research for health promotion and disease prevention and add preventive benefits (H.R. 3887), E270 [9MR]

———reductions in prescription drug prices, H579, H580 [1MR], H4916, H4920-H4928 [21JN]

———reductions in prescription drug prices (H.R. 664), H336 [10FE], H418-H425 [15FE], H458, H459, H460, H461 [16FE], H1461-H1463 [28MR], H3297-H3300 [17MY], H4659-H4664 [19JN], H7910, H7911 [20SE]

———reimbursement of prescription drug costs at the average wholesale price, E1524 [19SE], E1620, E1622 [28SE]

———reimbursement rates for drugs, E2194 [15DE]

———revise coverage of immunosuppressive drugs (H.R. 5276), E1581 [25SE]

———waive waiting period for coverage and provide coverage of drugs for amyotrophic lateral sclerosis, H12445, H12485 [15DE]

Medicare/Medicaid: reimbursement levels for chemotherapy drugs, E1578 [25SE]

Methamphetamine: penalties for operating laboratories and increased funding to combat methamphetamine production, trafficking, and abuse, H8253, H8254, H8260, H8261 [27SE]

Mexico: drug interdiction assistance, H3644 [23MY]

———foreign aid certification of drug enforcement efforts, H614 [1MR], H980 [14MR]

Middletown, NY: tribute to Periwinkle National Theatre for drug education efforts, E2115 [4DE]

Miller, Devin: FBI Director's Community Leadership Award recipient, E101 [9FE]

Milwaukee, WI: tribute to Thomas More High School Jennie Fund initiative to provide scholarships to students willing to participate in Students Against Destructive Decisions (SADD) program, E549 [12AP]

National Alcohol and Drug Addiction Recovery Month: support goals and ideas (H. Con. Res. 371), H6734 [24JY], E2126 [5DE]

National Biotechnology Month: observance, E20 [27JA], E30, E31, E36 [31JA], E49 [1FE]

National Vaccine Injury Compensation Program: amend (H.R. 5327), E1606 [27SE]

Nevada: tribute to prescription drug plan for senior citizens, H7219 [6SE]

NIH: biomedical research funding (H. Res. 437), H7072-H7085 [26JY]

Office of National Drug Control Policy: High Intensity Drug Trafficking Areas funding, H762 [9MR], H962 [14MR], H6624, H6625 [20JY]

———High Intensity Drug Trafficking Areas funding through reductions in IRS administrative account, H6642-H6645 [20JY]

———proposed program to encourage placement of anti-drug messages in television programing, H5741 [11JY]

Office of the U.S. Trade Representative: prohibit interference with certain foreign intellectual property laws or policies designed to make pharmaceuticals or medical technologies more affordable, H5151-H5153 [26JN]

Panama Canal: negotiate new agreement relative to the presence of U.S. Armed Forces, H6016 [13JY]

Patents: provide term restoration review procedure for certain drug products (H.R. 1598), E1581 [25SE]

———provide term restoration review procedure for certain drug products (S. 1172), E1581 [25SE]

Peru: elections, H3916 [6JN]

Pharmaceutical industry: require industry to disclose average prices charged for drugs in Organization for Economic Cooperation and Development countries, H5775, H5776 [11JY]

———research and development costs, E10 [27JA], E531 [11AP]

———research and development costs disclosure, H5774 [11JY]

Pharmaceuticals: eliminate barriers to improve access to generic drugs, H7742 [19SE], E1527, E1528, E1529 [19SE]

———impact of pharmaceutical company mergers on prices, competition, and research activities, E973 [12JN]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (H.R. 3636), E114 [10FE]

———reductions in prescription drug prices, H2096 [11AP], H5441 [29JN], H7908-H7915 [20SE], H8053 [25SE]

———reinstate reasonable pricing requirements for drugs developed with Federal funding or research, H4291-H4293 [13JN]

Prescription drugs: distribution (H.R. 4301), E586 [13AP]

Rasch, Sunna: Dept. of Education John Stanford Education Heroes Award recipient, E2115 [4DE]

Republican Party: national agenda, H8909-H8914 [5OC], H11201 [26OC], H11774-H11779 [1NO], H12053 [8DE]

Schools: provide notification to State educational agencies regarding the availability of funds to establish school safety hotlines (H.R. 5123), H7380-H7384 [12SE]

Senior citizens: limit hardship endured when meeting prescription drug needs (H. Con. Res. 152), H8796 [4OC]

Social Security: create a grant program to promote joint activities between Federal, State, and local child welfare and alcohol and drug abuse prevention and treatment agencies (H.R. 5081), E1366 [27JY]

States: clarify application of Federal controlled substances laws in States that authorize medical use of marijuana and other drugs (H.R. 4802), E1176 [30JN]

Substance abuse: allow faith-based treatment centers to receive Federal funding and permit individuals receiving Federal assistance to choose private and religious oriented treatment, H6820-H6823, H6826-H6837 [25JY], H8250, H8252, H8262 [27SE]

Substance Abuse and Mental Health Services Administration: promote State flexibility and accountability, support youth prevention and treatment programs, and respond to incidents of teen violence, H8262 [27SE]

———revise and extend programs (H.R. 4867), H6376, H6377 [18JY], H6474 [19JY], E1258 [18JY]

Taxation: allow a credit to individuals attaining age 65 for certain drug and health insurance expenses (H.R. 4234), H2019 [11AP]

———allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (H.R. 4472), H3058 [16MY]

———deny tax benefits for research conducted by pharmaceutical companies where U.S. consumers pay more for products of that research than foreign consumers (H.R. 3665), H2281 [13AP], E148 [15FE]

———treatment of certain gifts and benefits provided to physicians by prescription drug manufacturers (H.R. 4088), E411 [23MR], E417 [27MR]

———treatment of certain gifts and benefits provided to physicians by prescription drug manufacturers (H.R. 4089), H2280 [13AP], E411 [23MR], E417 [27MR], E886 [6JN]

———treatment of direct-to-consumer advertisements of prescription drugs that fail to provide certain information to the consumer (H.R. 4686), E1026 [15JN]

TEAM8 Communities Coalition: tribute to efforts to combat juvenile crime in Michigan communities, E1574 [22SE]

Tobacco products: regulation of tobacco industry to alleviate health risks to children, H1847-H1849 [5AP]

U.N. Drug Control Program: contributions by countries to fund activities, E95 [8FE]

U.S-Mexico Border Conference: meeting, H1768 [5AP]

Remarks in Senate

Animals: increase the availability of drugs for minor species and rare diseases in all animals (S. 3169), S9950 [5OC]

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (S. 2993), S7908 [27JY]

Armed Forces: expand authority for support for civilian law enforcement agencies, S64 [26JA]

Boehringer Ingelheim Pharmaceuticals, Inc.: offer of drug for the prevention of mother-to-child transmission of HIV to developing countries, S7421 [21JY]

Bolivia: tribute to democracy and drug eradication efforts (S. Res. 375), S10427 [12OC], S10840 [19OC]

Boys and Girls Clubs of America: National Training Center leadership development funding, S11865 [15DE]

Budget: ensure Medicare coverage of prescription drugs prior to consideration of any tax cuts, S2087-S2094 [4AP], S2145-S2155 [5AP], S2667, S2678 [13AP]

Coast Guard: funding, S1257, S1258 [8MR]

———maritime patrol aircraft funding, S4096 [17MY]

Colombia: authorize urgent support to secure peace and the rule of law, and to enhance the effectiveness of anti-drug efforts, S2655-S2660 [13AP], S4182-S4184 [18MY], S5313-S5315 [19JN], S5521-S5527, S5537-S5539, S5542-S5547 [21JN], S5618-S5620 [22JN], S11473-S11475 [1NO]

———certification of U.S. support for the Colombian Government, military, and rule of law relative to assistance, S5509 [21JN]

———condemn kidnapping of U.S. citizens by Revolutionary Armed Forces of Colombia (FARC) and encourage the European community to assist with their safe return, S5511 [21JN]

———condition aid on U.S. public support of anti-drug efforts, S5446, S5447 [20JN]

———drug interdiction assistance, S63-S65 [26JA], S2648, S2655-S2660 [13AP], S5313-S5315 [19JN], S5521-S5527 [21JN], S5618-S5620, S5623, S5626 [22JN], S6228-S6232, S6235 [30JN], S11473-S11475 [1NO]

———provide helicopters to assist in drug enforcement efforts, S5515-S5519, S5526, S5528, S5529 [21JN], S5626 [22JN]

Colorado: tribute to Grand Futures (organization) for efforts in drug control, S11558 [5DE]

Community Anti-Drug Coalitions of America: tribute to National Leadership Forum for efforts in drug control, S11558 [5DE]

Computers: enhance consumer protection in the purchase of prescription drugs from Internet pharmacies (S. 3208), S10620-S10623 [17OC]

Congress: accomplishments of the 106th Congress, S7496, S7503-S7509 [25JY], S10886 [23OC], S10899-S10901 [24OC], S10962 [25OC]

Consumers: allow importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale, S7142 [18JY], S7194-S7216 [19JY], S7377 [20JY]

———allow importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use, S9029 [22SE], S9255, S9258 [26SE], S10523 [13OC], S10669, S10675-S10678, S10681-S10688, S10691-S10698, S10732 [18OC]

———allow importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use (S. 2520), S3693-S3695 [9MY]

———discrepancy in prescription drug prices between U.S. and foreign countries, S1862 [29MR], S2320 [6AP], S8781-S8785 [20SE]

———extend interstate price discrimination prohibitions to foreign commerce relative to the discrepancy in prescription drug prices between U.S. and foreign countries, S4171 [18MY]

———extend interstate price discrimination prohibitions to foreign commerce relative to the discrepancy in prescription drug prices between U.S. and foreign countries (S. 2464), S2942 [26AP], S4171 [18MY]

———require the U.S. Trade Representative to enter into negotiations to eliminate price controls imposed by certain foreign countries on prescription drugs (S. 2466), S2944 [26AP]

Correctional institutions: authorize funding for successful reentry of criminal offenders into local communities (S. 2908), S7477 [24JY]

———establish grants for drug treatment alternatives to prison programs administered by State or local prosecutors (H.R. 4493), S11655 [6DE]

———substance abuse prevention and treatment programs in prisons funding (S. 2619), S4380 [24MY]

Courts: establish a Federal drug court program (S. 3191), S10415 [12OC]

Crime: combat manufacture, traffic, import, and export of methamphetamine, S5625 [22JN]

———national policy to control crime and reform court procedures (S. 2783), S5790 [26JN]

DEA: funding to assist State and local efforts to clean up methamphetamine laboratories, S5542 [21JN], S6465 [11JY], S7439 [21JY], S7459 [24JY]

———funding to assist State and local efforts to clean up methamphetamine laboratories (S. Res. 291), S2713, S2775, S2776 [13AP]

Democratic Party: national agenda, S10962 [25OC]

Dept. of Defense: increase cooperation with Cuba on drug interdiction efforts, S5533 [21JN]

———policy and guidelines on personnel activities in Colombia relative to anti-drug efforts, S5613, S5614 [22JN]

———prohibit the issuance of security clearances to employees or contractors with histories of criminal activity or substance abuse, S4651-S4656 [7JN], S6448 [11JY]

———Synthetic Aperture Radar facility funding, S7739 [27JY]

Dept. of Justice: drug prosecution and incarceration funding for county and local governments along the U.S.-Mexico border, S6670 [13JY]

Detroit, MI: tribute to ``Youth Connection'' campaign, S1881 [29MR]

Douglas, Bob: National Crime Prevention Council Mac Gray Award recipient, S10404 [12OC]

Drug abuse: combat ``Ecstasy'' production, abuse, and imports, and increase education and awareness on dangers, S2893 [26AP]

———combat ``Ecstasy'' production, abuse, and imports, and increase education and awareness on dangers (S. 2612), S4317 [23MY], S9846 [4OC]

———combat methamphetamine abuse, S74-S76 [26JA]

———combat methamphetamine production and abuse, S11530 [14NO]

———national drug control policy, S789 [24FE], S2648 [13AP], S2893 [26AP], S5313-S5315 [19JN], S9562-S9564 [2OC], S11236 [27OC]

Drug courts: tribute, S4294 [23MY]

FDA: facilitate the importation into the U.S. of certain approved drugs, S7142 [18JY]

———facilitate the importation into the U.S. of certain approved drugs (S. 1191), S132-S134 [31JA], S707, S708 [23FE], S840 [28FE]

———grant authority to regulate tobacco, S2411 [7AP]

———grant authority to regulate tobacco (S. 2333), S1990-S1993 [30MR]

———grant authority to regulate tobacco (S. 2379), S2350, S2351 [6AP]

———grant authority to regulate tobacco (S. 2566), S4016-S4018 [16MY]

———grant authority to regulate tobacco (S. 2568), S4018 [16MY]

———Office of Generic Drugs funding, S7329, S7330, S7376 [20JY]

Federal agencies: increase funding to law enforcement agencies to strengthen drug enforcement activities, S2648 [13AP]

Federal Employees Health Benefits Program: coverage of contraceptives under any plan providing prescription drug coverage, S8799 [20SE]

Foreign aid: Caribbean and South American nations drug interdiction assistance funding, S5511-S5515, S5525-S5527 [21JN]

———use of counter-drug military assistance for Colombia to fund domestic substance abuse and mental health services, S5487-S5508 [21JN]

Foreign policy: prohibit any agent of the U.S. from pressuring African countries to change or revoke laws aimed at increasing access to HIV/AIDS drugs, S3037-S3039 [27AP], S3471 [4MY], S3792-S3807, S3818, S3823 [10MY], S3860, S3868, S3871, S3876 [11MY]

Gallatin County, MT: tribute to Drug Treatment Court, S4007 [16MY]

Government regulations: registration requirements for practitioners who dispense narcotic drugs for maintenance or detoxification treatment, S9111-S9115 [22SE], S11892, S11893 [15DE]

Health: create a national voluntary reporting system to continually reduce medical errors and improve patient safety, S6212 [30JN]

———create a national voluntary reporting system to continually reduce medical errors and improve patient safety (S. 2743), S5268-S5271 [15JN]

———enhance the Nation's capacity to address public health threats and emergencies, S11307-S11314 [28OC]

———enhance the Nation's capacity to address public health threats and emergencies (S. 2731), S5115-S5117 [14JN]

———reduce accidental injury and death resulting from medical mistakes and reduce medication-related errors (S. 2038), S489-S491 [8FE]

———reduce accidental injury and death resulting from medical mistakes and reduce medication-related errors (S. 2738), S5263 [15JN]

———substance abuse prevention and treatment programs funding (S. 2527), S3735 [9MY]

Homeless: substance abuse prevention and treatment services funding, S6188 [30JN]

Individuals With Disabilities Education Act: authorize school personnel to discipline children with disabilities who engage in certain dangerous behavior, S3572-S3574 [8MY]

Law enforcement: develop and implement community policing and prosecutorial initiatives that address production, manufacture, distribution, importation, and use of illegal drugs (S. 2850), S6574 [12JY]

———Federal law enforcement agencies funding to strengthen drug enforcement activities, S5533 [21JN]

Medicaid: make drug pricing information available to the public (S. 2963), S7855-S7858 [27JY]

Medicare: allow tax deduction for Medigap and Medicare+Choice plans including outpatient prescription drug and long-term care benefits, and establish new Medigap policies including such benefits (S. 2237), S1411 [9MR]

———coverage of outpatient prescription drugs, S132-S134 [31JA], S657 [22FE], S705-S709 [23FE], S837 [28FE], S1188-S1191 [6MR], S1659 [23MR], S1698 [27MR], S1851-S1853 [29MR], S1947 [30MR], S2030 [3AP], S2059, S2063, S2084 [4AP], S2324 [6AP], S2390, S2427 [7AP], S2571 [12AP], S2675, S2676, S2681, S2683, S2688, S2689 [13AP], S2891, S2893 [26AP], S2958 [27AP], S4171 [18MY], S4513 [6JN], S4974-S4978 [13JN], S5609, S5636-S5641, S5643, S5645, S5646 [22JN], S5721, S5726, S5731 [23JN], S5779, S5786 [26JN], S6442, S6446 [11JY], S6632-S6636, S6643 [13JY], S6796 [14JY], S7006, S7050 [17JY], S7085 [18JY], S7627 [26JY], S7962, S7980 [5SE], S8045-S8048 [6SE], S8160 [7SE], S8245-S8250, S8272-S8274 [8SE], S8536-S8538, S8569, S8600-S8604 [14SE], S8629, S8630 [15SE], S8748-S8750 [19SE], S8773-S8776, S8780-S8789 [20SE], S9127 [25SE], S9334, S9335 [27SE], S9415-S9418, S9422 [28SE], S9565 [2OC], S9835-S9838 [4OC], S9923, S9927 [5OC], S10127-S10129 [10OC], S10667-S10669 [18OC], S10960-S10962, S10968 [25OC], S11065 [26OC], S11531 [14NO], S11564 [5DE]

———coverage of outpatient prescription drugs and enhanced preventative benefits (S. 2541), S3839-S3850 [10MY]

———coverage of outpatient prescription drugs for military retirees, S10383 [12OC]

———coverage of outpatient prescription drugs (S. 1480), S7, S8 [24JA], S124, S125 [31JA], S315 [3FE], S656 [22FE], S751-S753 [23FE], S787 [24FE], S1042 [1MR], S1162-S1164 [6MR], S1203 [7MR], S1267 [8MR], S1482 [21MR], S2032-S2034 [3AP], S3694 [9MY]

———coverage of outpatient prescription drugs (S. 1535), S104 [26JA], S5879 [27JN], S6253 [30JN]

———coverage of outpatient prescription drugs (S. 2758), S5465-S5467 [20JN], S5719 [23JN]

———coverage of outpatient prescription drugs (S. 2836), S8091-S8093 [6SE]

———coverage of outpatient prescription drugs (S. 3016), S8198-S8204 [7SE]

———coverage of outpatient prescription drugs (S. 3017), S8204 [7SE]

———coverage of outpatient prescription drugs (S. 3107), S9254 [26SE], S9357 [27SE]

———eliminate time limitation on benefits for immunosuppressive drugs (S. 2399), S2541 [11AP], S2713 [13AP]

———establish a voluntary plan under which eligible beneficiaries may elect to receive coverage for outpatient prescription drugs (S. 2319), S1899-S1901 [29MR], S2650-S2653 [13AP]

———expand coverage of certain self-injected biologicals, S11898 [15DE]

———expand coverage of certain self-injected biologicals (S. 2644), S4557 [6JN], S4921 [9JN]

———expand coverage of certain self-injected biologicals (S. 2957), S7849 [27JY]

———make improvements to the Medicare+Choice program, S10669 [18OC]

———make improvements to the Medicare+Choice program (S. 2905), S7449 [21JY]

———make more competitive and efficient and provide for a prescription drug benefit, S8775, S8869 [20SE]

———make more competitive and efficient and provide for a prescription drug benefit (H.R. 4680), S6182 [29JN], S6185 [30JN]

———make more competitive and efficient and provide for a prescription drug benefit (S. 2807), S6020 [28JN]

———promote research for health promotion and disease prevention and add preventive benefits, S8536, S8537 [14SE], S8748-S8750 [19SE]

———promote research for health promotion and disease prevention and add preventive benefits (S. 2232), S1400-S1402 [9MR]

———reductions in prescription drug prices, S2032-S2034 [3AP], S4974-S4978 [13JN], S9839 [4OC]

———reductions in prescription drug prices (S. 731), S838-S840 [28FE], S11564 [5DE]

———reimbursement levels for free-standing cancer hospitals for outpatient services, S11481 [1NO]

———waive waiting period for coverage and provide coverage of drugs for amyotrophic lateral sclerosis, S11225 [27OC], S11821 [15DE]

———waive waiting period for coverage and provide coverage of drugs for amyotrophic lateral sclerosis (S. 1074), S9889, S9890 [5OC]

———waive waiting period for coverage of amyotrophic lateral sclerosis, S6797 [14JY]

Methamphetamine: penalties for operating laboratories and increased funding to combat methamphetamine production, trafficking, and abuse, S9108 [22SE], S9187 [25SE]

Mexico: grant a temporary waiver of requirements relative to foreign aid certification of drug enforcement efforts (S. 3021), S8212-S8214, S8241 [7SE]

———grant a temporary waiver of requirements relative to foreign aid certification of drug enforcement efforts (S. Res. 366), S9884 [5OC], S10272 [11OC]

Montana: designate certain counties as High Intensity Drug Trafficking Areas and authorize funding for drug control activities in those areas (S. 2238), S1413 [9MR]

Naches, WA: Naches Valley High School Leadership Class recipient of Innovation in Education Award, S299 [2FE]

National Alcohol and Drug Addiction Recovery Month: designate (S. Res. 351), S8344 [11SE]

———support goals and ideas (H. Con. Res. 371), S8639 [15SE]

National Biotechnology Month: observance, S58-S63, S95 [26JA], S144-S146 [31JA]

National Community Antidrug Coalition Institute: establish (S. 2473), S2944 [26AP]

National Drug-Free Workplace Alliance: funding, S8746 [19SE]

National Eat-Dinner-With-Your-Children Day: designate (S. Res. 323), S5160 [14JN]

National Pharmacy Week: observance, S11491 [1NO]

Native Americans: allow purchase of prescription drugs from the Federal Supply Schedule, S7715 [26JY]

———authorize the integration and consolidation of alcohol and substance abuse programs and services provided by tribal governments (S. 1507), S5054, S5055 [13JN]

Nevada: National Guard Counterdrug Reconnaissance and Interdiction Detachment Unit funding, S7742 [27JY]

NIH: biomedical research funding (S. Res. 253), S383 [7FE], S488 [8FE]

———require proposal to ensure reasonable rate of return from drug manufacturers on drugs developed with Federal funding or research, S5832-S5834 [27JN]

NIST: establish a program to support research and training in methods of detecting the use of performance-enhancing substances by athletes (S. 2267), S1616 [22MR]

———establish a program to support research and training in methods of detecting the use of performance-enhancing substances by athletes (S. 2267), placed on the calendar, S1619 [23MR]

———establish a program to support research and training in methods of detecting the use of performance-enhancing substances by athletes (S. 2340), S7509-S7511, S7520, S7526-S7528 [25JY]

———establish a program to support research and training in methods of detecting the use of performance-enhancing substances by athletes (S. 2340), unanimous-consent request, S6056, S6057 [29JN]

Office of National Drug Control Policy: High Intensity Drug Trafficking Areas funding, S8746 [19SE]

Panama Canal: negotiate new agreement relative to the presence of U.S. Armed Forces (S. Res. 257), S638 [10FE]

Pharmaceutical industry: research and development costs, S1862 [29MR]

Pharmaceuticals: direct-to-consumer advertisements of prescription drugs, S11489 [1NO]

———provide access and choice for use of generic drugs under Federal health care programs (S. 2501), S3328 [3MY], S11564 [5DE]

———reinstate reasonable pricing requirements for drugs developed with Federal funding or research, S6096-S6099 [29JN], S6186 [30JN]

Schools: provide a safer educational environment by implementing policies to reduce violence and illegal drug use, S1071, S1072, S1097 [2MR], S2950-S2953 [27AP]

Senate: legislative priorities, S8041 [6SE]

Social Security: create a grant program to promote joint activities between Federal, State, and local child welfare and alcohol and drug abuse prevention and treatment agencies (S. 2435), S2745 [13AP]

Substance Abuse and Mental Health Services Administration: promote State flexibility and accountability, support youth prevention and treatment programs, and respond to incidents of teen violence, S9106, S9108 [22SE]

———promote State flexibility and accountability, support youth prevention and treatment programs, and respond to incidents of teen violence (S. 976), S9842 [4OC]

Tariff: R115777 (S. 2628), S4391 [24MY]

———(S)-6-chloro-3,4-dihydro-4-cyclopropylethynyl-4-trifluoromethyl-2(1H)-quinazolinone (S. 2391), S2532 [11AP]

———(S)-6-chloro-3,4-dihydro-4-E-cyclopropylethynyl-4-trifluoromethyl-2(1H)-quinazolinone (S. 2392), S2532 [11AP]

Taxation: deny tax benefits for research conducted by pharmaceutical companies where U.S. consumers pay more for products of that research than foreign consumers (S. 2465), S2943 [26AP]

———impose a discriminatory profits tax on pharmaceutical companies that charge higher prices to domestic wholesale distributors than to foreign wholesale distributors (S. 3103), S9199 [25SE]

Reports

Comparision Between House and Senate Legislation on Drug Interdiction Assistance to Colombia: Mary M. McCarthy and Helena Olea, Heartland Alliance for Human Needs & Human Rights, H5614 [29JN]

Country Reports on Human Rights Practices—Colombia: Dept. of State, S5490 [21JN]

Global Infectious Disease Threat: National Intelligence Council, S3823-S3825 [10MY]

NIH Biomedical Research Funding: Ad Hoc Group for Medical Research Funding, H7075-H7077 [26JY]

Prescription Drugs with Foreign Labels, H9674 [11OC]

Use of Armed Forces Personnel To Support Civilian Law Enforcement: Dept. of Defense, E794 [19MY]

Youth Challenge Case Study: Collette Caprara, H6829 [25JY]

Reports filed

Amateur Sports Integrity Act: Committee on Commerce, Science, and Transportation (Senate) (S. 2340) (S. Rept. 106-278), S3328 [3MY]

Consideration of H.R. 4680, Medicare Rx 2000 Act: Committee on Rules (House) (H. Res. 539) (H. Rept. 106-705), H5239 [27JN]

Dept. of Defense Anthrax Vaccine Immunization Program—Unproven Force Protection: Committee on Government Reform (House) (H. Rept. 106-556), H1674 [3AP]

Medicare Rx 2000 Act: Committee on Ways and Means (House) (H.R. 4680) (H. Rept. 106-703), H5239 [27JN]

Methamphetamine Anti-Proliferation Act: Committee on the Judiciary (House) (H.R. 2987) (H. Rept. 106-878), H7990 [21SE]

Native American Alcohol and Substance Abuse Program Consolidation Act: Committee on Indian Affairs (Senate) (S. 1507) (S. Rept. 106-306), S4564 [6JN]

Nomination of Donnie R. Marshall To Be DEA Administrator: Committee on the Judiciary (Senate), S3915 [11MY]

Nomination of Julio F. Mercado To Be DEA Deputy Administrator: Committee on the Judiciary (Senate), S5240 [15JN]

Public Health Threats and Emergencies Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 2731) (S. Rept. 106-505), S10715 [18OC]

U.S.-Panama Partnership Act: Committee on International Relations (House) (H.R. 3673) (H. Rept. 106-803), H7205 [27JY]

Resolutions by organizations

Hear O'Israel International, Inc., Listen to the Cries of the Children National Campaign 2000: Houston, TX, Mayor and City Council, E862 [25MY]

Rulings of the Chair

Medicare: make more competitive and efficient and provide for a prescription drug benefit (H.R. 4680), H5397 [28JN]

Statements

Biotechnology Research: National Research Council, S63 [26JA]

———President Clinton, S63 [26JA]

Buprenorphine Use in Treating Drug Addiction: Charles O'Brien, S9113 [22SE]

Colombia Answers Plan Colombia—A Plan for Peace or a Plan for War? Several Human Rights Organizations, S5491 [21JN]

District of Columbia Inclusion of Conscience Clause in Legislation Mandating Coverage of Contraceptives by Health Insurance Plans: Several District of Columbia City Council Members, H7057 [26JY]

Marijuana Legislation: Bryce James, Will W. Gusakov, and Jeremiah H. Spofford, E1484 [14SE]

Need for Alternative Activities To Keep Kids From Alcohol, Drugs and Tobacco: April Niles, Blake Kincaid, Craig Stevens, and Nate Powers, E1580 [25SE]

NIH Biomedical Research Funding: Biomedical Research Caucus, H7077 [26JY]

Power of Choice: Several Vermont High School Students, E1475 [13SE]

Prescription Drug Costs: Kayla Gildersleeve, Angela Deblasio, and Tess Grossi, E1579 [25SE]

Registration Requirements for Practitioners Who Dispense Narcotic Drugs for Maintenance or Detoxification Treatments: Representatives Bliley and McCollum, H8259 [27SE]

Voluntary Error Reduction and Improvement in Patient Safety Act: American Health Quality Association, S5270 [15JN]

Youth Challenge Program: Raul Gonzalez, H6828 [25JY]

Studies

Rural Case Studies on Medicare Prescription Drug Coverage, S8 [24JA]

Summaries

Internet Prescription Drug Consumer Protection Act (S. 3208), S10621 [17OC]

Voluntary Error Reduction and Improvement in Patient Safety Act (S. 2743), S5269 [15JN]

Tables

Comparision between the Voluntary Medicare Prescription Drug Plan Act and the Clinton administration proposal on Medicare coverage of outpatient prescription drugs, S2652, S2653 [13AP]

Comparision of prescription drug prices in Washington (State) and Canada, S2091 [4AP]

Comparison between George W. Bush's and Vice President Gore's Medicare reform plans, S10962 [25OC]

Economic costs of major illnesses, H7075 [26JY]

Prescription drug import provisions in agriculture appropriations legislation, S10525 [13OC]

Republican tax proposals effects on prescription drug prices, H2281 [13AP]

U.N. Drug Control Program funding pledges by countries, E96 [8FE]

Texts of

H. Con. Res. 371, support goals and ideas of National Alcohol and Drug Addiction Recovery Month, H6734 [24JY]

H. Res. 437, NIH biomedical research funding, H7072 [26JY]

H. Res. 539, consideration of H.R. 4680, Medicare Rx 2000 Act, H5300 [28JN]

H. Res. 672, encourage private-sector distributors of the influenza vaccine to give priority to distributing the available vaccine to individuals at a high risk of developing complications from influenza, E2160 [8DE]

H.R. 1042, Drug Dealer Liability Act, H9535 [10OC]

H.R. 2130, Date-Rape Drug Prohibition Act, H55-H57 [31JA]

H.R. 2634, Drug Addiction Treatment Act, H6374 [18JY], H7200 [27JY]

H.R. 3240, Drug Import Fairness Act, H5426 [28JN]

H.R. 4493, Prosecution Drug Treatment Alternative to Prison Act, H9952 [17OC]

H.R. 4680, Medicare Rx 2000 Act, H5319, H5334-H5349 [28JN]

H.R. 5123, School Safety Hotline Act, H7380 [12SE]

H.R. 5312, Protecting Our Children From Drugs Act, H9950 [17OC]

S. 1507, Native American Alcohol and Substance Abuse Program Consolidation Act, S5054 [13JN]

S. 2237, Seniors' Security Act, S1411-S1413 [9MR]

S. 2333, Tobacco Regulatory Fairness Act, S1991 [30MR]

S. 2399, Comprehensive Immunosuppressive Drug Coverage for Transplantation Patients Act, S2541 [11AP]

S. 2435, Child Protection/Alcohol and Drug Partnership Act, S2746-S2749 [13AP]

S. 2501, Generic Pharmaceutical Access and Choice for Consumers Act, S3329-S3331 [3MY]

S. 2517, School Safety Act, S3614 [8MY]

S. 2541, Medicare Expansion for Needed Drugs (MEND) Act, S3840-S3848 [10MY]

S. 2612, Ecstasy Anti-Proliferation Act, S9847 [4OC]

S. 2628, tariff on R115777, S4391 [24MY]

S. 2850, Community Oriented Policing Services Against Drugs Act, S6574 [12JY]

S. 2905, Medicare+Choice Program Improvement Act, S7450 [21JY]

S. 2908, Offender Reentry and Community Safety Act, S7478-S7482 [24JY]

S. 2957, Medicare Self-Administered Medications Act, S7849 [27JY]

S. 2993, Drug Competition Act, S7908 [27JY]

S. 3016, Medicare Temporary Drug Assistance Act, S8199-S8204 [7SE]

S. 3017, Medicare Temporary Drug Assistance Act, S8204-S8209 [7SE]

S. 3051, Greater Access to Affordable Pharmaceuticals Act, S8590 [14SE]

S. 3169, Minor Animal Species Health and Welfare Act, S9951-S9955 [5OC]

S. 3191, Drug Court Act, S10415 [12OC]

S. Res. 253, Biomedical Revitalization Resolution, S383 [7FE]

S. Res. 257, negotiate new agreement relative to the presence of U.S. Armed Forces at the Panama Canal, S637 [10FE]

S. Res. 291, DEA funding to assist State and local efforts to clean up methamphetamine laboratories, S2775 [13AP]

S. Res. 323, National Eat-Dinner-With-Your-Children Day, S5119, S5161 [14JN]

S. Res. 351, National Alcohol and Drug Addiction Recovery Month, S8344 [11SE]

S. Res. 366, grant Mexico a temporary waiver of requirements relative to foreign aid certification of drug enforcement efforts, S9864 [4OC], S9884 [5OC], S10272 [11OC]

S. Res. 375, tribute to democracy and drug eradication efforts in Bolivia, S10427 [12OC], S10840 [19OC]